nodes	percent_of_prediction	percent_of_DWPC	metapath
Clindamycin—CYP3A4—Tamoxifen—pancreatic cancer	0.0942	0.24	CbGbCtD
Clindamycin—CYP3A4—Erlotinib—pancreatic cancer	0.0801	0.204	CbGbCtD
Clindamycin—CYP3A4—Irinotecan—pancreatic cancer	0.0724	0.185	CbGbCtD
Clindamycin—CYP3A4—Docetaxel—pancreatic cancer	0.053	0.135	CbGbCtD
Clindamycin—CYP3A4—Sunitinib—pancreatic cancer	0.0528	0.135	CbGbCtD
Clindamycin—CYP3A4—Doxorubicin—pancreatic cancer	0.0395	0.101	CbGbCtD
Clindamycin—Oesophagitis—Doxorubicin—pancreatic cancer	0.000749	0.00123	CcSEcCtD
Clindamycin—Anaemia—Gemcitabine—pancreatic cancer	0.000748	0.00123	CcSEcCtD
Clindamycin—Vertigo—Irinotecan—pancreatic cancer	0.000746	0.00123	CcSEcCtD
Clindamycin—Rash maculo-papular—Doxorubicin—pancreatic cancer	0.000745	0.00123	CcSEcCtD
Clindamycin—Leukopenia—Irinotecan—pancreatic cancer	0.000743	0.00122	CcSEcCtD
Clindamycin—Thrombophlebitis—Epirubicin—pancreatic cancer	0.000743	0.00122	CcSEcCtD
Clindamycin—Anaemia—Fluorouracil—pancreatic cancer	0.000735	0.00121	CcSEcCtD
Clindamycin—Dyspnoea—Sunitinib—pancreatic cancer	0.000734	0.00121	CcSEcCtD
Clindamycin—Stevens-Johnson syndrome—Docetaxel—pancreatic cancer	0.000728	0.0012	CcSEcCtD
Clindamycin—Dyspepsia—Sunitinib—pancreatic cancer	0.000724	0.00119	CcSEcCtD
Clindamycin—Leukopenia—Gemcitabine—pancreatic cancer	0.000724	0.00119	CcSEcCtD
Clindamycin—Hypertension—Irinotecan—pancreatic cancer	0.000717	0.00118	CcSEcCtD
Clindamycin—Jaundice—Docetaxel—pancreatic cancer	0.000716	0.00118	CcSEcCtD
Clindamycin—Leukopenia—Fluorouracil—pancreatic cancer	0.000712	0.00117	CcSEcCtD
Clindamycin—Gastrointestinal disorder—Sunitinib—pancreatic cancer	0.00071	0.00117	CcSEcCtD
Clindamycin—Fatigue—Sunitinib—pancreatic cancer	0.000709	0.00117	CcSEcCtD
Clindamycin—Hypersensitivity—Tamoxifen—pancreatic cancer	0.000708	0.00116	CcSEcCtD
Clindamycin—Pain—Sunitinib—pancreatic cancer	0.000704	0.00116	CcSEcCtD
Clindamycin—Constipation—Sunitinib—pancreatic cancer	0.000704	0.00116	CcSEcCtD
Clindamycin—Discomfort—Irinotecan—pancreatic cancer	0.000699	0.00115	CcSEcCtD
Clindamycin—Hypertension—Gemcitabine—pancreatic cancer	0.000699	0.00115	CcSEcCtD
Clindamycin—Epistaxis—Docetaxel—pancreatic cancer	0.000693	0.00114	CcSEcCtD
Clindamycin—Asthenia—Tamoxifen—pancreatic cancer	0.000689	0.00113	CcSEcCtD
Clindamycin—Thrombophlebitis—Doxorubicin—pancreatic cancer	0.000687	0.00113	CcSEcCtD
Clindamycin—Agranulocytosis—Docetaxel—pancreatic cancer	0.000686	0.00113	CcSEcCtD
Clindamycin—Asthenia—Erlotinib—pancreatic cancer	0.000682	0.00112	CcSEcCtD
Clindamycin—Dermatitis exfoliative—Epirubicin—pancreatic cancer	0.000681	0.00112	CcSEcCtD
Clindamycin—Discomfort—Gemcitabine—pancreatic cancer	0.000681	0.00112	CcSEcCtD
Clindamycin—Pruritus—Tamoxifen—pancreatic cancer	0.00068	0.00112	CcSEcCtD
Clindamycin—Anaphylactic shock—Irinotecan—pancreatic cancer	0.000678	0.00111	CcSEcCtD
Clindamycin—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.000673	0.00111	CcSEcCtD
Clindamycin—Dermatitis bullous—Epirubicin—pancreatic cancer	0.000673	0.00111	CcSEcCtD
Clindamycin—Pruritus—Erlotinib—pancreatic cancer	0.000673	0.00111	CcSEcCtD
Clindamycin—Discomfort—Fluorouracil—pancreatic cancer	0.000669	0.0011	CcSEcCtD
Clindamycin—Anaphylactoid reaction—Epirubicin—pancreatic cancer	0.000664	0.00109	CcSEcCtD
Clindamycin—Thrombocytopenia—Irinotecan—pancreatic cancer	0.000664	0.00109	CcSEcCtD
Clindamycin—Anaphylactic shock—Gemcitabine—pancreatic cancer	0.00066	0.00109	CcSEcCtD
Clindamycin—Diarrhoea—Tamoxifen—pancreatic cancer	0.000657	0.00108	CcSEcCtD
Clindamycin—Body temperature increased—Sunitinib—pancreatic cancer	0.000651	0.00107	CcSEcCtD
Clindamycin—Abdominal pain—Sunitinib—pancreatic cancer	0.000651	0.00107	CcSEcCtD
Clindamycin—Diarrhoea—Erlotinib—pancreatic cancer	0.00065	0.00107	CcSEcCtD
Clindamycin—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.000649	0.00107	CcSEcCtD
Clindamycin—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.000646	0.00106	CcSEcCtD
Clindamycin—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.000636	0.00105	CcSEcCtD
Clindamycin—Dizziness—Tamoxifen—pancreatic cancer	0.000635	0.00104	CcSEcCtD
Clindamycin—Hypotension—Irinotecan—pancreatic cancer	0.000633	0.00104	CcSEcCtD
Clindamycin—Dermatitis exfoliative—Doxorubicin—pancreatic cancer	0.000631	0.00104	CcSEcCtD
Clindamycin—Dizziness—Erlotinib—pancreatic cancer	0.000629	0.00103	CcSEcCtD
Clindamycin—Erythema multiforme—Docetaxel—pancreatic cancer	0.000624	0.00103	CcSEcCtD
Clindamycin—Dermatitis bullous—Doxorubicin—pancreatic cancer	0.000623	0.00102	CcSEcCtD
Clindamycin—Hypotension—Gemcitabine—pancreatic cancer	0.000617	0.00101	CcSEcCtD
Clindamycin—Anaphylactoid reaction—Doxorubicin—pancreatic cancer	0.000615	0.00101	CcSEcCtD
Clindamycin—Flushing—Docetaxel—pancreatic cancer	0.000612	0.00101	CcSEcCtD
Clindamycin—Cardiac arrest—Epirubicin—pancreatic cancer	0.000611	0.00101	CcSEcCtD
Clindamycin—Vomiting—Tamoxifen—pancreatic cancer	0.000611	0.001	CcSEcCtD
Clindamycin—Hypotension—Fluorouracil—pancreatic cancer	0.000607	0.000998	CcSEcCtD
Clindamycin—Hypersensitivity—Sunitinib—pancreatic cancer	0.000606	0.000997	CcSEcCtD
Clindamycin—Rash—Tamoxifen—pancreatic cancer	0.000606	0.000996	CcSEcCtD
Clindamycin—Dermatitis—Tamoxifen—pancreatic cancer	0.000605	0.000995	CcSEcCtD
Clindamycin—Vomiting—Erlotinib—pancreatic cancer	0.000604	0.000994	CcSEcCtD
Clindamycin—Dyspnoea—Irinotecan—pancreatic cancer	0.000604	0.000994	CcSEcCtD
Clindamycin—Headache—Tamoxifen—pancreatic cancer	0.000602	0.00099	CcSEcCtD
Clindamycin—Rash—Erlotinib—pancreatic cancer	0.000599	0.000986	CcSEcCtD
Clindamycin—Dermatitis—Erlotinib—pancreatic cancer	0.000599	0.000985	CcSEcCtD
Clindamycin—Dyspepsia—Irinotecan—pancreatic cancer	0.000597	0.000981	CcSEcCtD
Clindamycin—Headache—Erlotinib—pancreatic cancer	0.000596	0.000979	CcSEcCtD
Clindamycin—Asthenia—Sunitinib—pancreatic cancer	0.00059	0.000971	CcSEcCtD
Clindamycin—Dry skin—Epirubicin—pancreatic cancer	0.000589	0.000969	CcSEcCtD
Clindamycin—Dyspnoea—Gemcitabine—pancreatic cancer	0.000589	0.000968	CcSEcCtD
Clindamycin—Abdominal pain upper—Epirubicin—pancreatic cancer	0.000587	0.000966	CcSEcCtD
Clindamycin—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000585	0.000963	CcSEcCtD
Clindamycin—Fatigue—Irinotecan—pancreatic cancer	0.000584	0.000961	CcSEcCtD
Clindamycin—Pruritus—Sunitinib—pancreatic cancer	0.000582	0.000958	CcSEcCtD
Clindamycin—Pain—Irinotecan—pancreatic cancer	0.00058	0.000953	CcSEcCtD
Clindamycin—Constipation—Irinotecan—pancreatic cancer	0.00058	0.000953	CcSEcCtD
Clindamycin—Toxic epidermal necrolysis—Epirubicin—pancreatic cancer	0.000579	0.000952	CcSEcCtD
Clindamycin—Dyspnoea—Fluorouracil—pancreatic cancer	0.000579	0.000952	CcSEcCtD
Clindamycin—Erythema—Docetaxel—pancreatic cancer	0.000574	0.000944	CcSEcCtD
Clindamycin—Dyspepsia—Fluorouracil—pancreatic cancer	0.000571	0.00094	CcSEcCtD
Clindamycin—Nausea—Tamoxifen—pancreatic cancer	0.000571	0.000939	CcSEcCtD
Clindamycin—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.00057	0.000938	CcSEcCtD
Clindamycin—Fatigue—Gemcitabine—pancreatic cancer	0.000569	0.000936	CcSEcCtD
Clindamycin—Cardiac arrest—Doxorubicin—pancreatic cancer	0.000566	0.000931	CcSEcCtD
Clindamycin—Pain—Gemcitabine—pancreatic cancer	0.000565	0.000929	CcSEcCtD
Clindamycin—Constipation—Gemcitabine—pancreatic cancer	0.000565	0.000929	CcSEcCtD
Clindamycin—Nausea—Erlotinib—pancreatic cancer	0.000565	0.000929	CcSEcCtD
Clindamycin—Diarrhoea—Sunitinib—pancreatic cancer	0.000563	0.000926	CcSEcCtD
Clindamycin—Dysgeusia—Docetaxel—pancreatic cancer	0.000562	0.000925	CcSEcCtD
Clindamycin—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.00056	0.000922	CcSEcCtD
Clindamycin—Abdominal distension—Epirubicin—pancreatic cancer	0.00056	0.00092	CcSEcCtD
Clindamycin—Back pain—Docetaxel—pancreatic cancer	0.000555	0.000913	CcSEcCtD
Clindamycin—Pain—Fluorouracil—pancreatic cancer	0.000555	0.000913	CcSEcCtD
Clindamycin—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000554	0.000912	CcSEcCtD
Clindamycin—Muscle spasms—Docetaxel—pancreatic cancer	0.000552	0.000908	CcSEcCtD
Clindamycin—Eosinophilia—Epirubicin—pancreatic cancer	0.00055	0.000905	CcSEcCtD
Clindamycin—Dry skin—Doxorubicin—pancreatic cancer	0.000545	0.000897	CcSEcCtD
Clindamycin—Dizziness—Sunitinib—pancreatic cancer	0.000544	0.000895	CcSEcCtD
Clindamycin—Abdominal pain upper—Doxorubicin—pancreatic cancer	0.000543	0.000894	CcSEcCtD
Clindamycin—Abdominal pain—Irinotecan—pancreatic cancer	0.000536	0.000881	CcSEcCtD
Clindamycin—Body temperature increased—Irinotecan—pancreatic cancer	0.000536	0.000881	CcSEcCtD
Clindamycin—Toxic epidermal necrolysis—Doxorubicin—pancreatic cancer	0.000536	0.000881	CcSEcCtD
Clindamycin—Anaemia—Docetaxel—pancreatic cancer	0.000531	0.000873	CcSEcCtD
Clindamycin—Vomiting—Sunitinib—pancreatic cancer	0.000523	0.000861	CcSEcCtD
Clindamycin—Body temperature increased—Gemcitabine—pancreatic cancer	0.000522	0.000859	CcSEcCtD
Clindamycin—Dysuria—Epirubicin—pancreatic cancer	0.00052	0.000855	CcSEcCtD
Clindamycin—Neutropenia—Epirubicin—pancreatic cancer	0.00052	0.000855	CcSEcCtD
Clindamycin—Rash—Sunitinib—pancreatic cancer	0.000519	0.000853	CcSEcCtD
Clindamycin—Dermatitis—Sunitinib—pancreatic cancer	0.000518	0.000853	CcSEcCtD
Clindamycin—Abdominal distension—Doxorubicin—pancreatic cancer	0.000518	0.000851	CcSEcCtD
Clindamycin—Upper respiratory tract infection—Epirubicin—pancreatic cancer	0.000517	0.00085	CcSEcCtD
Clindamycin—Urticaria—Fluorouracil—pancreatic cancer	0.000516	0.000848	CcSEcCtD
Clindamycin—Headache—Sunitinib—pancreatic cancer	0.000516	0.000848	CcSEcCtD
Clindamycin—Leukopenia—Docetaxel—pancreatic cancer	0.000514	0.000845	CcSEcCtD
Clindamycin—Body temperature increased—Fluorouracil—pancreatic cancer	0.000513	0.000844	CcSEcCtD
Clindamycin—Eosinophilia—Doxorubicin—pancreatic cancer	0.000509	0.000837	CcSEcCtD
Clindamycin—Photosensitivity reaction—Epirubicin—pancreatic cancer	0.000507	0.000834	CcSEcCtD
Clindamycin—Hypersensitivity—Irinotecan—pancreatic cancer	0.000499	0.000821	CcSEcCtD
Clindamycin—Hypertension—Docetaxel—pancreatic cancer	0.000496	0.000815	CcSEcCtD
Clindamycin—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.000491	0.000808	CcSEcCtD
Clindamycin—Nausea—Sunitinib—pancreatic cancer	0.000489	0.000804	CcSEcCtD
Clindamycin—Asthenia—Irinotecan—pancreatic cancer	0.000486	0.0008	CcSEcCtD
Clindamycin—Jaundice—Epirubicin—pancreatic cancer	0.000483	0.000794	CcSEcCtD
Clindamycin—Urinary tract infection—Epirubicin—pancreatic cancer	0.000482	0.000792	CcSEcCtD
Clindamycin—Neutropenia—Doxorubicin—pancreatic cancer	0.000481	0.000791	CcSEcCtD
Clindamycin—Dysuria—Doxorubicin—pancreatic cancer	0.000481	0.000791	CcSEcCtD
Clindamycin—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000478	0.000787	CcSEcCtD
Clindamycin—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	0.000478	0.000786	CcSEcCtD
Clindamycin—Asthenia—Gemcitabine—pancreatic cancer	0.000474	0.000779	CcSEcCtD
Clindamycin—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.000469	0.000772	CcSEcCtD
Clindamycin—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000469	0.000771	CcSEcCtD
Clindamycin—Epistaxis—Epirubicin—pancreatic cancer	0.000467	0.000769	CcSEcCtD
Clindamycin—Pruritus—Gemcitabine—pancreatic cancer	0.000467	0.000768	CcSEcCtD
Clindamycin—Diarrhoea—Irinotecan—pancreatic cancer	0.000464	0.000763	CcSEcCtD
Clindamycin—Agranulocytosis—Epirubicin—pancreatic cancer	0.000462	0.000761	CcSEcCtD
Clindamycin—Pruritus—Fluorouracil—pancreatic cancer	0.000459	0.000755	CcSEcCtD
Clindamycin—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000459	0.000755	CcSEcCtD
Clindamycin—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.000455	0.000748	CcSEcCtD
Clindamycin—Diarrhoea—Gemcitabine—pancreatic cancer	0.000452	0.000743	CcSEcCtD
Clindamycin—Dizziness—Irinotecan—pancreatic cancer	0.000448	0.000737	CcSEcCtD
Clindamycin—Jaundice—Doxorubicin—pancreatic cancer	0.000447	0.000735	CcSEcCtD
Clindamycin—Urinary tract infection—Doxorubicin—pancreatic cancer	0.000446	0.000733	CcSEcCtD
Clindamycin—Diarrhoea—Fluorouracil—pancreatic cancer	0.000444	0.000731	CcSEcCtD
Clindamycin—Hypotension—Docetaxel—pancreatic cancer	0.000438	0.00072	CcSEcCtD
Clindamycin—Epistaxis—Doxorubicin—pancreatic cancer	0.000432	0.000711	CcSEcCtD
Clindamycin—Vomiting—Irinotecan—pancreatic cancer	0.000431	0.000709	CcSEcCtD
Clindamycin—Dizziness—Fluorouracil—pancreatic cancer	0.000429	0.000706	CcSEcCtD
Clindamycin—Agranulocytosis—Doxorubicin—pancreatic cancer	0.000428	0.000704	CcSEcCtD
Clindamycin—Rash—Irinotecan—pancreatic cancer	0.000427	0.000703	CcSEcCtD
Clindamycin—Dermatitis—Irinotecan—pancreatic cancer	0.000427	0.000702	CcSEcCtD
Clindamycin—Headache—Irinotecan—pancreatic cancer	0.000425	0.000698	CcSEcCtD
Clindamycin—Erythema multiforme—Epirubicin—pancreatic cancer	0.000421	0.000692	CcSEcCtD
Clindamycin—Vomiting—Gemcitabine—pancreatic cancer	0.00042	0.00069	CcSEcCtD
Clindamycin—Dyspnoea—Docetaxel—pancreatic cancer	0.000418	0.000687	CcSEcCtD
Clindamycin—Rash—Gemcitabine—pancreatic cancer	0.000416	0.000685	CcSEcCtD
Clindamycin—Dermatitis—Gemcitabine—pancreatic cancer	0.000416	0.000684	CcSEcCtD
Clindamycin—Headache—Gemcitabine—pancreatic cancer	0.000414	0.00068	CcSEcCtD
Clindamycin—Flushing—Epirubicin—pancreatic cancer	0.000413	0.000679	CcSEcCtD
Clindamycin—Vomiting—Fluorouracil—pancreatic cancer	0.000413	0.000679	CcSEcCtD
Clindamycin—Dyspepsia—Docetaxel—pancreatic cancer	0.000412	0.000678	CcSEcCtD
Clindamycin—Rash—Fluorouracil—pancreatic cancer	0.000409	0.000673	CcSEcCtD
Clindamycin—Dermatitis—Fluorouracil—pancreatic cancer	0.000409	0.000673	CcSEcCtD
Clindamycin—Headache—Fluorouracil—pancreatic cancer	0.000407	0.000669	CcSEcCtD
Clindamycin—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000405	0.000665	CcSEcCtD
Clindamycin—Fatigue—Docetaxel—pancreatic cancer	0.000404	0.000664	CcSEcCtD
Clindamycin—Nausea—Irinotecan—pancreatic cancer	0.000403	0.000662	CcSEcCtD
Clindamycin—Pain—Docetaxel—pancreatic cancer	0.000401	0.000659	CcSEcCtD
Clindamycin—Constipation—Docetaxel—pancreatic cancer	0.000401	0.000659	CcSEcCtD
Clindamycin—Nausea—Gemcitabine—pancreatic cancer	0.000392	0.000645	CcSEcCtD
Clindamycin—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000389	0.00064	CcSEcCtD
Clindamycin—Erythema—Epirubicin—pancreatic cancer	0.000387	0.000637	CcSEcCtD
Clindamycin—Nausea—Fluorouracil—pancreatic cancer	0.000386	0.000634	CcSEcCtD
Clindamycin—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000383	0.00063	CcSEcCtD
Clindamycin—Flushing—Doxorubicin—pancreatic cancer	0.000382	0.000628	CcSEcCtD
Clindamycin—Flatulence—Epirubicin—pancreatic cancer	0.000382	0.000628	CcSEcCtD
Clindamycin—Dysgeusia—Epirubicin—pancreatic cancer	0.000379	0.000624	CcSEcCtD
Clindamycin—Back pain—Epirubicin—pancreatic cancer	0.000375	0.000616	CcSEcCtD
Clindamycin—Muscle spasms—Epirubicin—pancreatic cancer	0.000372	0.000612	CcSEcCtD
Clindamycin—Abdominal pain—Docetaxel—pancreatic cancer	0.00037	0.000609	CcSEcCtD
Clindamycin—Body temperature increased—Docetaxel—pancreatic cancer	0.00037	0.000609	CcSEcCtD
Clindamycin—Erythema—Doxorubicin—pancreatic cancer	0.000358	0.000589	CcSEcCtD
Clindamycin—Anaemia—Epirubicin—pancreatic cancer	0.000358	0.000589	CcSEcCtD
Clindamycin—Flatulence—Doxorubicin—pancreatic cancer	0.000353	0.000581	CcSEcCtD
Clindamycin—Dysgeusia—Doxorubicin—pancreatic cancer	0.000351	0.000577	CcSEcCtD
Clindamycin—Vertigo—Epirubicin—pancreatic cancer	0.000348	0.000572	CcSEcCtD
Clindamycin—Leukopenia—Epirubicin—pancreatic cancer	0.000347	0.00057	CcSEcCtD
Clindamycin—Back pain—Doxorubicin—pancreatic cancer	0.000347	0.00057	CcSEcCtD
Clindamycin—Hypersensitivity—Docetaxel—pancreatic cancer	0.000345	0.000568	CcSEcCtD
Clindamycin—Muscle spasms—Doxorubicin—pancreatic cancer	0.000345	0.000567	CcSEcCtD
Clindamycin—Asthenia—Docetaxel—pancreatic cancer	0.000336	0.000553	CcSEcCtD
Clindamycin—Hypertension—Epirubicin—pancreatic cancer	0.000334	0.00055	CcSEcCtD
Clindamycin—Pruritus—Docetaxel—pancreatic cancer	0.000332	0.000545	CcSEcCtD
Clindamycin—Anaemia—Doxorubicin—pancreatic cancer	0.000331	0.000545	CcSEcCtD
Clindamycin—Discomfort—Epirubicin—pancreatic cancer	0.000326	0.000536	CcSEcCtD
Clindamycin—Vertigo—Doxorubicin—pancreatic cancer	0.000322	0.000529	CcSEcCtD
Clindamycin—Leukopenia—Doxorubicin—pancreatic cancer	0.000321	0.000528	CcSEcCtD
Clindamycin—Diarrhoea—Docetaxel—pancreatic cancer	0.000321	0.000527	CcSEcCtD
Clindamycin—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000316	0.00052	CcSEcCtD
Clindamycin—Dizziness—Docetaxel—pancreatic cancer	0.00031	0.00051	CcSEcCtD
Clindamycin—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000309	0.000509	CcSEcCtD
Clindamycin—Hypertension—Doxorubicin—pancreatic cancer	0.000309	0.000509	CcSEcCtD
Clindamycin—Discomfort—Doxorubicin—pancreatic cancer	0.000301	0.000496	CcSEcCtD
Clindamycin—Vomiting—Docetaxel—pancreatic cancer	0.000298	0.00049	CcSEcCtD
Clindamycin—Rash—Docetaxel—pancreatic cancer	0.000295	0.000486	CcSEcCtD
Clindamycin—Hypotension—Epirubicin—pancreatic cancer	0.000295	0.000486	CcSEcCtD
Clindamycin—Dermatitis—Docetaxel—pancreatic cancer	0.000295	0.000485	CcSEcCtD
Clindamycin—Headache—Docetaxel—pancreatic cancer	0.000294	0.000483	CcSEcCtD
Clindamycin—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000292	0.000481	CcSEcCtD
Clindamycin—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000286	0.000471	CcSEcCtD
Clindamycin—Dyspnoea—Epirubicin—pancreatic cancer	0.000282	0.000463	CcSEcCtD
Clindamycin—Nausea—Docetaxel—pancreatic cancer	0.000278	0.000458	CcSEcCtD
Clindamycin—Dyspepsia—Epirubicin—pancreatic cancer	0.000278	0.000458	CcSEcCtD
Clindamycin—Hypotension—Doxorubicin—pancreatic cancer	0.000273	0.000449	CcSEcCtD
Clindamycin—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000273	0.000449	CcSEcCtD
Clindamycin—Fatigue—Epirubicin—pancreatic cancer	0.000272	0.000448	CcSEcCtD
Clindamycin—Pain—Epirubicin—pancreatic cancer	0.00027	0.000445	CcSEcCtD
Clindamycin—Constipation—Epirubicin—pancreatic cancer	0.00027	0.000445	CcSEcCtD
Clindamycin—Dyspnoea—Doxorubicin—pancreatic cancer	0.000261	0.000429	CcSEcCtD
Clindamycin—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000258	0.000425	CcSEcCtD
Clindamycin—Dyspepsia—Doxorubicin—pancreatic cancer	0.000257	0.000423	CcSEcCtD
Clindamycin—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000252	0.000415	CcSEcCtD
Clindamycin—Fatigue—Doxorubicin—pancreatic cancer	0.000252	0.000415	CcSEcCtD
Clindamycin—Urticaria—Epirubicin—pancreatic cancer	0.000251	0.000413	CcSEcCtD
Clindamycin—Constipation—Doxorubicin—pancreatic cancer	0.00025	0.000411	CcSEcCtD
Clindamycin—Pain—Doxorubicin—pancreatic cancer	0.00025	0.000411	CcSEcCtD
Clindamycin—Abdominal pain—Epirubicin—pancreatic cancer	0.00025	0.000411	CcSEcCtD
Clindamycin—Body temperature increased—Epirubicin—pancreatic cancer	0.00025	0.000411	CcSEcCtD
Clindamycin—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000239	0.000393	CcSEcCtD
Clindamycin—Hypersensitivity—Epirubicin—pancreatic cancer	0.000233	0.000383	CcSEcCtD
Clindamycin—Urticaria—Doxorubicin—pancreatic cancer	0.000232	0.000382	CcSEcCtD
Clindamycin—Body temperature increased—Doxorubicin—pancreatic cancer	0.000231	0.00038	CcSEcCtD
Clindamycin—Abdominal pain—Doxorubicin—pancreatic cancer	0.000231	0.00038	CcSEcCtD
Clindamycin—Asthenia—Epirubicin—pancreatic cancer	0.000227	0.000373	CcSEcCtD
Clindamycin—Pruritus—Epirubicin—pancreatic cancer	0.000224	0.000368	CcSEcCtD
Clindamycin—Diarrhoea—Epirubicin—pancreatic cancer	0.000216	0.000356	CcSEcCtD
Clindamycin—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000215	0.000354	CcSEcCtD
Clindamycin—Asthenia—Doxorubicin—pancreatic cancer	0.00021	0.000345	CcSEcCtD
Clindamycin—Dizziness—Epirubicin—pancreatic cancer	0.000209	0.000344	CcSEcCtD
Clindamycin—Pruritus—Doxorubicin—pancreatic cancer	0.000207	0.00034	CcSEcCtD
Clindamycin—Vomiting—Epirubicin—pancreatic cancer	0.000201	0.000331	CcSEcCtD
Clindamycin—Diarrhoea—Doxorubicin—pancreatic cancer	0.0002	0.000329	CcSEcCtD
Clindamycin—Rash—Epirubicin—pancreatic cancer	0.000199	0.000328	CcSEcCtD
Clindamycin—Dermatitis—Epirubicin—pancreatic cancer	0.000199	0.000327	CcSEcCtD
Clindamycin—Headache—Epirubicin—pancreatic cancer	0.000198	0.000326	CcSEcCtD
Clindamycin—Dizziness—Doxorubicin—pancreatic cancer	0.000193	0.000318	CcSEcCtD
Clindamycin—Nausea—Epirubicin—pancreatic cancer	0.000188	0.000309	CcSEcCtD
Clindamycin—Vomiting—Doxorubicin—pancreatic cancer	0.000186	0.000306	CcSEcCtD
Clindamycin—Rash—Doxorubicin—pancreatic cancer	0.000184	0.000303	CcSEcCtD
Clindamycin—Dermatitis—Doxorubicin—pancreatic cancer	0.000184	0.000303	CcSEcCtD
Clindamycin—Headache—Doxorubicin—pancreatic cancer	0.000183	0.000301	CcSEcCtD
Clindamycin—Nausea—Doxorubicin—pancreatic cancer	0.000174	0.000286	CcSEcCtD
